| Full Name | Jennifer Kaskey |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 162 560th St, Alta, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780138057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 02718 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Kaskey, 162 560th St, Alta, IA 51002-7541 Ph: (712) 333-1887 | Jennifer Kaskey, 162 560th St, Alta, IA 51002-7541 Ph: (712) 333-1887 |
News Archive
A team of Ludwig Cancer Research scientists has mapped out how a mutant version of the epidermal growth factor receptor (EGFR) known as EGFRvIII specifically drives critical processes that alter the reading of the genome to fuel the growth of the brain cancer glioblastoma multiforme (GBM) and-most important-how each process is linked to the other.
Calculating blood pressure load does not increase physicians' ability to predict a patient's risk of cardiovascular events, research shows.
To coincide with World Health Day on Thursday, the Infectious Diseases Society of America (IDSA) released a policy paper with nine recommendations for how to control the "ever-growing threat of antimicrobial resistance," CIDRAP News reports.
A new study from Linköping University has shown that the tumour-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children.
Drugs that pharmaceutical companies market most aggressively to physicians and patients tend to offer less benefit and more harm to most patients - a phenomenon described as the "inverse benefit law" in a paper from the University of Texas Medical Branch at Galveston.
› Verified 1 days ago